You are here

IGF::OT::IGF SBIR TOPIC 379: DIGIBIOMARC: DIGITAL BIOMARKERS FOR CLINICAL IMPACT- MOONSHOT PROJECT(FAST TRACK)

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 75N91018C00010
Agency Tracking Number: N43CA180010
Amount: $1,499,800.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NCI
Solicitation Number: N/A
Timeline
Solicitation Year: 2018
Award Year: 2019
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
525 UNIVERSITY AVE, PALO ALTO, CA, 94301-2238
DUNS: 078739184
HUBZone Owned: N
Woman Owned: Y
Socially and Economically Disadvantaged: N
Principal Investigator
 Michelle Longmire
 (505) 463-8394
 michelle@medable.com
Business Contact
 Michelle Longmire
Phone: (505) 463-8394
Email: michelle@medable.com
Research Institution
N/A
Abstract
The overall objective of this Fast Track SBIR contract project is to develop DigiBioMarCTMDigital BioMarkers for Clinical Impacta scalable and flexible cloud based platform to capture and analyze wearableimplantableor external device dataThis platform also provides an informatics tool for automated data aggregationintegrationand machine learning algorithmsIt is based on the scalable user centered Medable platformwhich implements standardization and normalization of patient generated data to drive health insightsDigiBioMarCTM will compare and combine disparate data streams to understand contextualized patient physiology in real time in order to identify disease and or detect changes in disease health statusIt also will support cohort and clinical studiesparticularly those testing digital biomarkers from wearable sensor technologiesThis Fast Track project will focus on product development with an ultimate aim of a product that improves cancer research data and clinical trialsenhances clinical careand that can be used to engage patients in preventive health behaviors and treatment adherenceThe Phase I goal is to develop a data agnostic DigiBioMarCTM prototype for validation in Phase IIThe PhaseGo No Go decision point to proceed to Phase II will be a working prototype with specified features for further development and validation in Phase II

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government